Table 1 Demographic and clinical characteristics of acute ischemic stroke patients with incidence of dyslipidemia.
From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia
| Â | rtPA | No rtPA | p-value |
|---|---|---|---|
Number of Patients | 325 | 444 | Â |
Age Group: No. (%) | |||
 <50 years | 28 (8.6) | 25 (5.6) | 0.004* |
 50-59 | 62 (19.1) | 52 (11.7) | |
 60-69 | 80 (24.6) | 99 (22.3) | |
 70-79 | 75 (23.1) | 129 (29.1) | |
 >80 years | 80 (24.6) | 139 (31.3) | |
Mean ± SD | 68.25±13.4 | 71.90±12.8 | 0.333 |
Gender: No. (%) | |||
 Male | 182 (56.0) | 203 (45.7) | 0.006* |
 Female | 143 (44.0) | 241 (54.3) | |
Race: No. (%) | |||
 Caucasian | 266 (81.8) | 361 (81.3) | 0.920 |
 African-American | 55 (16.9) | 76 (17.1) | |
 Other | 4 (1.2) | 7 (1.6) | |
Medical History: No. (%) | |||
 Hypertension | 298 (91.7) | 390 (87.8) | 0.096 |
 Coronary Artery Disease | 124 (38.2) | 183 (41.2) | 0.413 |
 Atrial Fib/Flutter | 56 (17.2) | 124 (27.9) | 0.001* |
 Previous Stroke | 90 (27.7) | 166 (37.4) | 0.005* |
 Previous TIA | 46 (14.2) | 57 (12.8) | 0.594 |
 Congestive Heart Failure | 33 (10.2) | 69 (15.5) | 0.031* |
 Carotid Artery Stenosis | 14 (4.3) | 44 (9.9) | 0.004* |
 Peripheral Vascular Disease | 26 (8.0) | 43 (9.7) | 0.446 |
 History of Smoking | 93 (28.6) | 83 (18.7) | 0.001* |
 Diabetes | 112 (34.5) | 181 (40.8) | 0.084 |
Medication History: No. (%) | |||
 Antiplatelet | 215 (66.2) | 297 (66.9) | 0.877 |
 Antihypertension | 285 (87.7) | 366 (82.4) | 0.054 |
 Cholesterol Reducer | 252 (77.5) | 336 (75.7) | 0.606 |
 Diabetes Medication | 91 (28.0) | 140 (31.5) | 0.302 |
Initial NIH Stroke Scale Group: No. (%) | |||
 0-9 | 203 (62.5) | 317 (71.4) | 0.077 |
 10-14 | 44 (13.5) | 46 (10.4) | |
 15-20 | 41 (12.6) | 43 (9.7) | |
 21-25 | 37 (11.4) | 38 (8.6) | |
Mean ± SD | 9.42±6.6 | 7.37±6.6 | 0.565 |
Risk of Mortality GWTG Ischemic Stroke: | |||
 Mean ± SD | 5.45±6.0 | 4.62±5.3 | 0.093 |
Body Mass Index | |||
 Mean ± SD | 29.10±6.7 | 28.68±7.2 | 0.264 |